
Chinese General Practice ›› 2024, Vol. 27 ›› Issue (19): 2364-2374.DOI: 10.12114/j.issn.1007-9572.2023.0472
Special Issue: 内分泌代谢性疾病最新文章合辑; 老年问题最新文章合辑; 老年人群健康最新文章合辑
• Article • Previous Articles Next Articles
Received:2023-06-14
Revised:2024-02-26
Published:2024-07-05
Online:2024-04-28
Contact:
ZHU Hong
通讯作者:
朱宏
作者简介:作者贡献:
黄书玮参与文章构思与设计、数据收集与管理、论文写作;周志衡、冯天元、刘莉参与文章构思与设计、数据收集与管理、论文修订;邓光璞、李尧天参与文章构思与设计、统计分析、审查和论文写作;朱宏负责文章构思与设计、文章的质量控制及审校,对文章整体负责。
基金资助:CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0472
| 序号 | 公式 |
|---|---|
| 式(1) | BMI=体质量/身高2 |
| 式(2) | TyG指数=ln[TG×FBG/2] |
| 式(3) | TyG-BMI指数=TyG指数×BMI |
| 式(4) | TyG-WC指数=TyG指数×WC |
| 式(5) | TG/HDL-C指数=TG/HDL-C |
| 式(6) | Non-HDL-C/HDL-C指数=(TC-HDL-C)/HDL-C |
| 式(7) | METS-IR指数= {ln[2×FPG+TG]×BMI/ln [HDL-C]} |
| 式(8) | LCI指数=TC×TG×LDL-C/HDL-C |
| 式(9) | CI指数=(LDL-C-HDL-C)(TG<400 mg/dL)或LDL-C-HDL-C+TG/5(TG≥400 mg/dL) |
Table 1 Indicator calculation formula
| 序号 | 公式 |
|---|---|
| 式(1) | BMI=体质量/身高2 |
| 式(2) | TyG指数=ln[TG×FBG/2] |
| 式(3) | TyG-BMI指数=TyG指数×BMI |
| 式(4) | TyG-WC指数=TyG指数×WC |
| 式(5) | TG/HDL-C指数=TG/HDL-C |
| 式(6) | Non-HDL-C/HDL-C指数=(TC-HDL-C)/HDL-C |
| 式(7) | METS-IR指数= {ln[2×FPG+TG]×BMI/ln [HDL-C]} |
| 式(8) | LCI指数=TC×TG×LDL-C/HDL-C |
| 式(9) | CI指数=(LDL-C-HDL-C)(TG<400 mg/dL)或LDL-C-HDL-C+TG/5(TG≥400 mg/dL) |
| 组别 | 例数 | 性别[例(%)] | 高血压[例(%)] | 吸烟[例(%)] | |||
|---|---|---|---|---|---|---|---|
| 男 | 女 | 否 | 是 | 否 | 是 | ||
| NHUA组 | 1 528 | 838(54.84) | 690(45.16) | 775(49.28) | 753(50.72) | 1 131(74.02) | 387(25.98) |
| HUA组 | 479 | 336(70.15) | 143(29.85) | 184(38.41) | 295(61.59) | 334(69.73) | 145(30.27) |
| χ2值 | 35.177 | 22.136 | 3.403 | ||||
| P值 | <0.001 | <0.001 | 0.065 | ||||
| 组别 | 饮酒[例(%)] | 运动[例(%)] | 年龄( | T2DM病程( | WC( | ||
| 否 | 是 | 否 | 是 | ||||
| NHUA组 | 1 326(86.13) | 212(13.87) | 856(56.02) | 672(43.98) | 57.74±11.15 | 70.86±79.77 | 0.87±0.08 |
| HUA组 | 401(83.72) | 78(16.28) | 243(50.73) | 236(49.27) | 57.62±12.16 | 69.23±66.01 | 0.95±0.06 |
| χ2(t)值 | 1.713a | 4.12a | -0.197 | -0.404 | 19.539 | ||
| P值 | 0.191 | 0.042 | 0.844 | 0.686 | <0.001 | ||
| 组别 | BMI( | SBP( | DBP( | FPG( | HbA1c( | ALT( | AST( |
| NHUA组 | 24.18±2.63 | 130±15 | 79±9 | 7.46±1.45 | 7.48±1.70 | 25.29±6.64 | 22.57±7.02 |
| HUA组 | 26.02±2.97 | 132±15 | 81±9 | 8.01±2.48 | 7.63±2.05 | 27.65±5.05 | 23.82±5.67 |
| t值 | 12.969 | 3.211 | 3.738 | 5.925 | 0.878 | 1.804 | 1.467 |
| P值 | <0.001 | 0.001 | <0.001 | <0.001 | 0.38 | 0.071 | 0.143 |
| 组别 | Scr( | TC( | TG( | LDL-C( | HDL-C( | TyG指数( | TyG-BMI指数( |
| NHUA组 | 68.87±16.54 | 5.01±1.01 | 1.60±1.22 | 3.10±0.97 | 1.53±0.58 | 9.02±0.66 | 218.27±29.52 |
| HUA组 | 85.91±25.49 | 5.16±0.98 | 2.66±1.63 | 3.93±1.51 | 1.19±0.35 | 9.49±0.70 | 247.08±35.58 |
| t值 | 8.37 | 2.835 | 14.014 | 2.133 | -18.025 | 14.626 | 17.711 |
| P值 | <0.001 | 0.005 | <0.001 | 0.033 | <0.001 | <0.001 | <0.001 |
| 组别 | TyG-WC指数( | TG/HDL-C指数( | Non-HDL-C/HDL-C指数( | METS IR指数( | LCI指数( | CI指数( | |
| NHUA组 | 7.89±0.98 | 2.59±1.64 | 2.40±0.90 | 35.90±5.05 | 65 760.34±57 498.98 | 60.66±39.75 | |
| HUA组 | 9.03±0.88 | 5.91±3.61 | 3.60±1.85 | 42.77±7.25 | 176 633.54±368 874.82 | 105.97±58.56 | |
| t值 | 22.844 | 15.92 | 19.049 | 23.215 | 11.324 | 3.004 | |
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
Table 2 Comparison of general information and clinical data between HUA group and NHUA group
| 组别 | 例数 | 性别[例(%)] | 高血压[例(%)] | 吸烟[例(%)] | |||
|---|---|---|---|---|---|---|---|
| 男 | 女 | 否 | 是 | 否 | 是 | ||
| NHUA组 | 1 528 | 838(54.84) | 690(45.16) | 775(49.28) | 753(50.72) | 1 131(74.02) | 387(25.98) |
| HUA组 | 479 | 336(70.15) | 143(29.85) | 184(38.41) | 295(61.59) | 334(69.73) | 145(30.27) |
| χ2值 | 35.177 | 22.136 | 3.403 | ||||
| P值 | <0.001 | <0.001 | 0.065 | ||||
| 组别 | 饮酒[例(%)] | 运动[例(%)] | 年龄( | T2DM病程( | WC( | ||
| 否 | 是 | 否 | 是 | ||||
| NHUA组 | 1 326(86.13) | 212(13.87) | 856(56.02) | 672(43.98) | 57.74±11.15 | 70.86±79.77 | 0.87±0.08 |
| HUA组 | 401(83.72) | 78(16.28) | 243(50.73) | 236(49.27) | 57.62±12.16 | 69.23±66.01 | 0.95±0.06 |
| χ2(t)值 | 1.713a | 4.12a | -0.197 | -0.404 | 19.539 | ||
| P值 | 0.191 | 0.042 | 0.844 | 0.686 | <0.001 | ||
| 组别 | BMI( | SBP( | DBP( | FPG( | HbA1c( | ALT( | AST( |
| NHUA组 | 24.18±2.63 | 130±15 | 79±9 | 7.46±1.45 | 7.48±1.70 | 25.29±6.64 | 22.57±7.02 |
| HUA组 | 26.02±2.97 | 132±15 | 81±9 | 8.01±2.48 | 7.63±2.05 | 27.65±5.05 | 23.82±5.67 |
| t值 | 12.969 | 3.211 | 3.738 | 5.925 | 0.878 | 1.804 | 1.467 |
| P值 | <0.001 | 0.001 | <0.001 | <0.001 | 0.38 | 0.071 | 0.143 |
| 组别 | Scr( | TC( | TG( | LDL-C( | HDL-C( | TyG指数( | TyG-BMI指数( |
| NHUA组 | 68.87±16.54 | 5.01±1.01 | 1.60±1.22 | 3.10±0.97 | 1.53±0.58 | 9.02±0.66 | 218.27±29.52 |
| HUA组 | 85.91±25.49 | 5.16±0.98 | 2.66±1.63 | 3.93±1.51 | 1.19±0.35 | 9.49±0.70 | 247.08±35.58 |
| t值 | 8.37 | 2.835 | 14.014 | 2.133 | -18.025 | 14.626 | 17.711 |
| P值 | <0.001 | 0.005 | <0.001 | 0.033 | <0.001 | <0.001 | <0.001 |
| 组别 | TyG-WC指数( | TG/HDL-C指数( | Non-HDL-C/HDL-C指数( | METS IR指数( | LCI指数( | CI指数( | |
| NHUA组 | 7.89±0.98 | 2.59±1.64 | 2.40±0.90 | 35.90±5.05 | 65 760.34±57 498.98 | 60.66±39.75 | |
| HUA组 | 9.03±0.88 | 5.91±3.61 | 3.60±1.85 | 42.77±7.25 | 176 633.54±368 874.82 | 105.97±58.56 | |
| t值 | 22.844 | 15.92 | 19.049 | 23.215 | 11.324 | 3.004 | |
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
| 变量 | B | SE | OR(95%CI) | Wald χ2值 | P值 |
|---|---|---|---|---|---|
| 性别(以男性为对照) | |||||
| 女性 | -0.660 | 0.112 | 0.517(0.415~0.644) | 34.533 | <0.001 |
| 吸烟(以不吸烟为对照) | |||||
| 吸烟 | 0.213 | 0.115 | 1.237(0.987~1.550) | 3.397 | 0.065 |
| 饮酒(以不喝酒为对照) | |||||
| 喝酒 | 0.189 | 0.144 | 1.207(0.910~1.602) | 1.709 | 0.191 |
| 运动(以不锻炼为对照) | |||||
| 锻炼 | 0.213 | 0.105 | 0.808(0.658~0.993) | 4.113 | 0.043 |
| 高血压(以非高血压为对照) | |||||
| 高血压 | 0.501 | 0.107 | 1.650(1.338~2.035) | 21.921 | <0.001 |
| 年龄 | -0.001 | 0.005 | 0.999(0.990~1.008) | 0.039 | 0.844 |
| 病程 | 0.000 | 0.001 | 1.000(0.998~1.001) | 0.163 | 0.686 |
| WC | 0.145 | 0.009 | 1.156(1.136~1.176) | 263.989 | <0.001 |
| BMI | 0.233 | 0.020 | 1.262(1.214~1.312) | 136.975 | <0.001 |
| SBP | 0.011 | 0.004 | 1.011(1.004~1.019) | 10.207 | 0.001 |
| DBP | 0.021 | 0.006 | 1.021(1.010~1.033) | 13.766 | <0.001 |
| FPG | 0.162 | 0.028 | 1.176(1.112~1.244) | 32.427 | <0.001 |
| HbA1c | 0.012 | 0.014 | 1.012(0.984~1.040) | 0.675 | 0.411 |
| ALT | 0.003 | 0.002 | 1.003(0.999~1.007) | 2.733 | 0.098 |
| AST | 0.004 | 0.003 | 1.004(0.998~1.010) | 1.862 | 0.172 |
| Scr | 0.016 | 0.002 | 1.016(1.012~1.020) | 60.549 | <0.001 |
| TC | 0.144 | 0.051 | 1.154(1.044~1.276) | 7.902 | 0.005 |
| TG | 0.645 | 0.053 | 1.905(1.716~2.115) | 146.439 | <0.001 |
| LDL-C | 0.149 | 0.055 | 1.161(1.041~1.294) | 7.239 | 0.007 |
| HDL-C | -3.699 | 0.223 | 0.250(0.160~0.380) | 275.394 | <0.001 |
| TyG指数 | 1.213 | 0.094 | 3.365(2.796~4.049) | 165.149 | <0.001 |
| TyG-BMI指数 | 0.028 | 0.002 | 1.029(1.025~1.032) | 221.724 | <0.001 |
| TyG-WC指数 | 1.310 | 0.074 | 3.705(3.204~4.285) | 311.638 | <0.001 |
| TG/HDL-C指数 | 0.398 | 0.027 | 1.489(1.411~1.571) | 211.636 | <0.001 |
| Non-HDL-C/HDL-C指数 | 1.110 | 0.063 | 3.034(2.680~3.436) | 126.324 | <0.001 |
| METS_IR指数 | 0.205 | 0.012 | 1.228(1.200~1.256) | 308.428 | <0.001 |
| LCI指数 | 0.000 | 0.000 | 1.000(1.000~1.000) | 169.924 | <0.001 |
| CI指数 | 0.014 | 0.002 | 1.014(1.011~1.017) | 75.331 | <0.001 |
Table 3 Univariate Logistic regression analysis of HUA occurrence in middle-aged and elderly T2DM patients
| 变量 | B | SE | OR(95%CI) | Wald χ2值 | P值 |
|---|---|---|---|---|---|
| 性别(以男性为对照) | |||||
| 女性 | -0.660 | 0.112 | 0.517(0.415~0.644) | 34.533 | <0.001 |
| 吸烟(以不吸烟为对照) | |||||
| 吸烟 | 0.213 | 0.115 | 1.237(0.987~1.550) | 3.397 | 0.065 |
| 饮酒(以不喝酒为对照) | |||||
| 喝酒 | 0.189 | 0.144 | 1.207(0.910~1.602) | 1.709 | 0.191 |
| 运动(以不锻炼为对照) | |||||
| 锻炼 | 0.213 | 0.105 | 0.808(0.658~0.993) | 4.113 | 0.043 |
| 高血压(以非高血压为对照) | |||||
| 高血压 | 0.501 | 0.107 | 1.650(1.338~2.035) | 21.921 | <0.001 |
| 年龄 | -0.001 | 0.005 | 0.999(0.990~1.008) | 0.039 | 0.844 |
| 病程 | 0.000 | 0.001 | 1.000(0.998~1.001) | 0.163 | 0.686 |
| WC | 0.145 | 0.009 | 1.156(1.136~1.176) | 263.989 | <0.001 |
| BMI | 0.233 | 0.020 | 1.262(1.214~1.312) | 136.975 | <0.001 |
| SBP | 0.011 | 0.004 | 1.011(1.004~1.019) | 10.207 | 0.001 |
| DBP | 0.021 | 0.006 | 1.021(1.010~1.033) | 13.766 | <0.001 |
| FPG | 0.162 | 0.028 | 1.176(1.112~1.244) | 32.427 | <0.001 |
| HbA1c | 0.012 | 0.014 | 1.012(0.984~1.040) | 0.675 | 0.411 |
| ALT | 0.003 | 0.002 | 1.003(0.999~1.007) | 2.733 | 0.098 |
| AST | 0.004 | 0.003 | 1.004(0.998~1.010) | 1.862 | 0.172 |
| Scr | 0.016 | 0.002 | 1.016(1.012~1.020) | 60.549 | <0.001 |
| TC | 0.144 | 0.051 | 1.154(1.044~1.276) | 7.902 | 0.005 |
| TG | 0.645 | 0.053 | 1.905(1.716~2.115) | 146.439 | <0.001 |
| LDL-C | 0.149 | 0.055 | 1.161(1.041~1.294) | 7.239 | 0.007 |
| HDL-C | -3.699 | 0.223 | 0.250(0.160~0.380) | 275.394 | <0.001 |
| TyG指数 | 1.213 | 0.094 | 3.365(2.796~4.049) | 165.149 | <0.001 |
| TyG-BMI指数 | 0.028 | 0.002 | 1.029(1.025~1.032) | 221.724 | <0.001 |
| TyG-WC指数 | 1.310 | 0.074 | 3.705(3.204~4.285) | 311.638 | <0.001 |
| TG/HDL-C指数 | 0.398 | 0.027 | 1.489(1.411~1.571) | 211.636 | <0.001 |
| Non-HDL-C/HDL-C指数 | 1.110 | 0.063 | 3.034(2.680~3.436) | 126.324 | <0.001 |
| METS_IR指数 | 0.205 | 0.012 | 1.228(1.200~1.256) | 308.428 | <0.001 |
| LCI指数 | 0.000 | 0.000 | 1.000(1.000~1.000) | 169.924 | <0.001 |
| CI指数 | 0.014 | 0.002 | 1.014(1.011~1.017) | 75.331 | <0.001 |
| 变量 | 模型1 | 模型2 | 模型3 | |||
|---|---|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
| BMI | 1.072(1.021~1.125) | 0.005 | 1.081(1.031~1.133) | <0.001 | ||
| WC | 1.130(1.108~1.153) | <0.001 | 1.118(1.097~1.140) | <0.001 | ||
| Scr | 1.014(1.010~1.018) | <0.001 | 1.014(1.010~1.018) | <0.001 | 1.014(1.010~1.018) | <0.001 |
| TyG指数 | 2.849(2.347~3.561) | <0.001 | ||||
| TyG-BMI指数 | 1.018(1.014~1.023) | <0.001 | ||||
| TyG-WC指数 | 3.411(2.916~3.991) | <0.001 | ||||
| 变量 | 模型4 | 模型5 | 模型6 | |||
| OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
| BMI | 1.064(1.013~1.119) | 0.014 | 1.061(1.008~1.116) | <0.001 | ||
| WC | 1.132(1.109~1.156) | <0.001 | 1.140(1.116~1.164) | <0.001 | 1.103(1.081~1.125) | <0.001 |
| Scr | 1.012(1.008~1.016) | <0.001 | 1.011(1.007~1.015) | <0.001 | 1.013(1.008~1.017) | <0.001 |
| TG/HDL-C指数 | 1.425(1.344~1.510) | <0.001 | ||||
| Non-HDL-C/HDL-C指数 | 2.847(2.483~3.264) | <0.001 | ||||
| METS-IR指数 | 1.170(1.142~1.200) | <0.001 | ||||
Table 4 Multivariate Logistic regression analysis of HUA occurrence in middle-aged and elderly T2DM patients
| 变量 | 模型1 | 模型2 | 模型3 | |||
|---|---|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
| BMI | 1.072(1.021~1.125) | 0.005 | 1.081(1.031~1.133) | <0.001 | ||
| WC | 1.130(1.108~1.153) | <0.001 | 1.118(1.097~1.140) | <0.001 | ||
| Scr | 1.014(1.010~1.018) | <0.001 | 1.014(1.010~1.018) | <0.001 | 1.014(1.010~1.018) | <0.001 |
| TyG指数 | 2.849(2.347~3.561) | <0.001 | ||||
| TyG-BMI指数 | 1.018(1.014~1.023) | <0.001 | ||||
| TyG-WC指数 | 3.411(2.916~3.991) | <0.001 | ||||
| 变量 | 模型4 | 模型5 | 模型6 | |||
| OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
| BMI | 1.064(1.013~1.119) | 0.014 | 1.061(1.008~1.116) | <0.001 | ||
| WC | 1.132(1.109~1.156) | <0.001 | 1.140(1.116~1.164) | <0.001 | 1.103(1.081~1.125) | <0.001 |
| Scr | 1.012(1.008~1.016) | <0.001 | 1.011(1.007~1.015) | <0.001 | 1.013(1.008~1.017) | <0.001 |
| TG/HDL-C指数 | 1.425(1.344~1.510) | <0.001 | ||||
| Non-HDL-C/HDL-C指数 | 2.847(2.483~3.264) | <0.001 | ||||
| METS-IR指数 | 1.170(1.142~1.200) | <0.001 | ||||
| 变量 | OR(95%CI) | P值 | |
|---|---|---|---|
| TyG指数 | Q1 | ||
| Q2 | 1.543(0.937~2.149) | <0.084 | |
| Q3 | 2.487(1.628~3.346) | <0.001 | |
| Q4 | 3.941(2.286~5.435) | <0.001 | |
| TyG-BMI指数 | Q1 | ||
| Q2 | 2.252(1.420~3.572) | 0.001 | |
| Q3 | 2.949(1.883~4.617) | <0.001 | |
| Q4 | 4.735(3.035~7.389) | <0.001 | |
| TyG-WC指数 | Q1 | ||
| Q2 | 2.955(2.201~3.709) | <0.001 | |
| Q3 | 3.509(2.462~4.556) | <0.001 | |
| Q4 | 5.184(3.850~6.518) | <0.001 | |
| TG/HDL-C指数 | Q1 | ||
| Q2 | 1.034(0.726~1.342) | 0.297 | |
| Q3 | 2.863(2.023~3.703) | <0.001 | |
| Q4 | 3.554(2.421~4.687) | <0.001 | |
| Non HDL-C/HDL-C指数 | Q1 | ||
| Q2 | 1.443(0.720~2.889) | 0.301 | |
| Q3 | 2.551(1.482~4.390) | <0.001 | |
| Q4 | 4.375(2.337~8.192) | <0.001 | |
| METS-IR指数 | Q1 | ||
| Q2 | 2.568(1.526~4.322) | <0.001 | |
| Q3 | 3.473(2.097~5.752) | <0.001 | |
| Q4 | 4.725(2.453~6.997) | <0.001 |
Table 5 Multivariate Logistic regression analysis of 6 insulin resistance replacement indexes for the occurrence of HUA
| 变量 | OR(95%CI) | P值 | |
|---|---|---|---|
| TyG指数 | Q1 | ||
| Q2 | 1.543(0.937~2.149) | <0.084 | |
| Q3 | 2.487(1.628~3.346) | <0.001 | |
| Q4 | 3.941(2.286~5.435) | <0.001 | |
| TyG-BMI指数 | Q1 | ||
| Q2 | 2.252(1.420~3.572) | 0.001 | |
| Q3 | 2.949(1.883~4.617) | <0.001 | |
| Q4 | 4.735(3.035~7.389) | <0.001 | |
| TyG-WC指数 | Q1 | ||
| Q2 | 2.955(2.201~3.709) | <0.001 | |
| Q3 | 3.509(2.462~4.556) | <0.001 | |
| Q4 | 5.184(3.850~6.518) | <0.001 | |
| TG/HDL-C指数 | Q1 | ||
| Q2 | 1.034(0.726~1.342) | 0.297 | |
| Q3 | 2.863(2.023~3.703) | <0.001 | |
| Q4 | 3.554(2.421~4.687) | <0.001 | |
| Non HDL-C/HDL-C指数 | Q1 | ||
| Q2 | 1.443(0.720~2.889) | 0.301 | |
| Q3 | 2.551(1.482~4.390) | <0.001 | |
| Q4 | 4.375(2.337~8.192) | <0.001 | |
| METS-IR指数 | Q1 | ||
| Q2 | 2.568(1.526~4.322) | <0.001 | |
| Q3 | 3.473(2.097~5.752) | <0.001 | |
| Q4 | 4.725(2.453~6.997) | <0.001 |
| 变量 | AUC | OR(95%CI) | 灵敏度(%) | 特异度(%) | 最佳截断值 | 约登指数 |
|---|---|---|---|---|---|---|
| TyG指数 | 0.677 | (0.650,0.703) | 89.80 | 65.30 | 8.78 | 0.245 |
| TyG-BMI指数 | 0.731 | (0.706,0.756) | 59.50 | 25.90 | 234.90 | 0.336 |
| TyG-WC指数 | 0.811 | (0.792,0.830) | 84.80 | 37.90 | 8.20 | 0.469 |
| TG/HDL-C指数 | 0.757 | (0.733,0.780) | 82.30 | 45.70 | 2.28 | 0.366 |
| Non-HDL-C/HDL-C指数 | 0.796 | (0.773,0.819) | 77.50 | 30.30 | 2.76 | 0.472 |
| METS-IR指数 | 0.791 | (0.768,0.814) | 64.50 | 22.00 | 39.61 | 0.425 |
| 男性 | ||||||
| TyG指数 | 0.655 | (0.622,0.688) | 88.70 | 65.90 | 8.77 | 0.228 |
| TyG-BMI指数 | 0.701 | (0.669,0.733) | 58.60 | 29.70 | 234.48 | 0.289 |
| TyG-WC指数 | 0.770 | (0.742,0.797) | 72.60 | 34.10 | 8.46 | 0.385 |
| TG/HDL-C指数 | 0.733 | (0.703,0.763) | 84.20 | 49.30 | 2.28 | 0.349 |
| Non-HDL-C/HDL-C指数 | 0.785 | (0.756,0.814) | 75.90 | 30.70 | 2.82 | 0.452 |
| METS-IR指数 | 0.765 | (0.735,0.795) | 62.80 | 23.30 | 40.16 | 0.395 |
| 女性 | ||||||
| TyG指数 | 0.719 | (0.675,0.763) | 66.40 | 37.00 | 9.20 | 0.294 |
| TyG-BMI指数 | 0.770 | (0.737,0.817) | 67.80 | 25.50 | 232.53 | 0.423 |
| TyG-WC指数 | 0.864 | (0.838,0.890) | 87.40 | 26.80 | 8.28 | 0.606 |
| TG/HDL-C指数 | 0.782 | (0.742,0.822) | 51.70 | 11.90 | 3.97 | 0.398 |
| Non-HDL-C/HDL-C指数 | 0.808 | (0.771,0.845) | 78.30 | 26.70 | 2.76 | 0.516 |
| METS-IR指数 | 0.822 | (0.786,0.857) | 81.80 | 33.00 | 36.81 | 0.488 |
Table 6 ROC curve and subgroup analysis of different insulin resistance replacement indexes for the risk of HUA in T2DM patients
| 变量 | AUC | OR(95%CI) | 灵敏度(%) | 特异度(%) | 最佳截断值 | 约登指数 |
|---|---|---|---|---|---|---|
| TyG指数 | 0.677 | (0.650,0.703) | 89.80 | 65.30 | 8.78 | 0.245 |
| TyG-BMI指数 | 0.731 | (0.706,0.756) | 59.50 | 25.90 | 234.90 | 0.336 |
| TyG-WC指数 | 0.811 | (0.792,0.830) | 84.80 | 37.90 | 8.20 | 0.469 |
| TG/HDL-C指数 | 0.757 | (0.733,0.780) | 82.30 | 45.70 | 2.28 | 0.366 |
| Non-HDL-C/HDL-C指数 | 0.796 | (0.773,0.819) | 77.50 | 30.30 | 2.76 | 0.472 |
| METS-IR指数 | 0.791 | (0.768,0.814) | 64.50 | 22.00 | 39.61 | 0.425 |
| 男性 | ||||||
| TyG指数 | 0.655 | (0.622,0.688) | 88.70 | 65.90 | 8.77 | 0.228 |
| TyG-BMI指数 | 0.701 | (0.669,0.733) | 58.60 | 29.70 | 234.48 | 0.289 |
| TyG-WC指数 | 0.770 | (0.742,0.797) | 72.60 | 34.10 | 8.46 | 0.385 |
| TG/HDL-C指数 | 0.733 | (0.703,0.763) | 84.20 | 49.30 | 2.28 | 0.349 |
| Non-HDL-C/HDL-C指数 | 0.785 | (0.756,0.814) | 75.90 | 30.70 | 2.82 | 0.452 |
| METS-IR指数 | 0.765 | (0.735,0.795) | 62.80 | 23.30 | 40.16 | 0.395 |
| 女性 | ||||||
| TyG指数 | 0.719 | (0.675,0.763) | 66.40 | 37.00 | 9.20 | 0.294 |
| TyG-BMI指数 | 0.770 | (0.737,0.817) | 67.80 | 25.50 | 232.53 | 0.423 |
| TyG-WC指数 | 0.864 | (0.838,0.890) | 87.40 | 26.80 | 8.28 | 0.606 |
| TG/HDL-C指数 | 0.782 | (0.742,0.822) | 51.70 | 11.90 | 3.97 | 0.398 |
| Non-HDL-C/HDL-C指数 | 0.808 | (0.771,0.845) | 78.30 | 26.70 | 2.76 | 0.516 |
| METS-IR指数 | 0.822 | (0.786,0.857) | 81.80 | 33.00 | 36.81 | 0.488 |
| 变量 | HUA | NHUA | 合计 |
|---|---|---|---|
| TyG-WC指数 | |||
| 高 | 42 | 371 | 413 |
| 低 | 32 | 510 | 542 |
| 合计 | 74 | 881 | 955 |
| Non-HDL-C/HDL-C指数 | |||
| 高 | 46 | 430 | 476 |
| 低 | 28 | 451 | 479 |
| 合计 | 74 | 881 | 955 |
| METS-IR指数 | |||
| 高 | 36 | 318 | 354 |
| 低 | 38 | 563 | 601 |
| 合计 | 74 | 881 | 955 |
Table 7 Nested case-control analysis of HUA occurrence
| 变量 | HUA | NHUA | 合计 |
|---|---|---|---|
| TyG-WC指数 | |||
| 高 | 42 | 371 | 413 |
| 低 | 32 | 510 | 542 |
| 合计 | 74 | 881 | 955 |
| Non-HDL-C/HDL-C指数 | |||
| 高 | 46 | 430 | 476 |
| 低 | 28 | 451 | 479 |
| 合计 | 74 | 881 | 955 |
| METS-IR指数 | |||
| 高 | 36 | 318 | 354 |
| 低 | 38 | 563 | 601 |
| 合计 | 74 | 881 | 955 |
| 变量 | 血糖控制不佳 | 血糖控制良好 | 合计 |
|---|---|---|---|
| TyG-WC指数 | |||
| 高 | 221 | 192 | 413 |
| 低 | 145 | 397 | 542 |
| 合计 | 366 | 589 | 955 |
| Non-HDL-C/HDL-C指数 | |||
| 高 | 216 | 260 | 476 |
| 低 | 150 | 329 | 479 |
| 合计 | 366 | 589 | 955 |
| METS-IR指数 | |||
| 高 | 186 | 168 | 354 |
| 低 | 180 | 421 | 601 |
| 合计 | 366 | 589 | 955 |
Table 8 Nested case-control study of blood glucose control in diabetic patients
| 变量 | 血糖控制不佳 | 血糖控制良好 | 合计 |
|---|---|---|---|
| TyG-WC指数 | |||
| 高 | 221 | 192 | 413 |
| 低 | 145 | 397 | 542 |
| 合计 | 366 | 589 | 955 |
| Non-HDL-C/HDL-C指数 | |||
| 高 | 216 | 260 | 476 |
| 低 | 150 | 329 | 479 |
| 合计 | 366 | 589 | 955 |
| METS-IR指数 | |||
| 高 | 186 | 168 | 354 |
| 低 | 180 | 421 | 601 |
| 合计 | 366 | 589 | 955 |
| [1] |
|
| [2] |
中华医学会糖尿病学分会胰岛素抵抗学组(筹). 胰岛素抵抗评估方法和应用的专家指导意见[J]. 中华糖尿病杂志,2018,10(6):377-385. DOI:10.3760/cma.j.issn.1674-5809.2018.06.001.
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
宋华隆,高鹰. 血尿酸水平与2型糖尿病发病风险的关联队列研究[J]. 中国全科医学,2023,26(15):1831-1839. DOI:10.12114/j.issn.1007-9572.2022.0785.
|
| [11] |
段琼,张紫行,徐娟,等. 高尿酸血症与脂肪肝关联的前瞻性队列研究[J]. 中华疾病控制杂志,2022,26(12):1420-1425,1432. DOI:10.16462/j.cnki.zhjbkz.2022.12.010.
|
| [12] |
|
| [13] |
李歆旎,沈艳,金雪娟,等. 血尿酸与高血压的相关性研究[J]. 中国分子心脏病学杂志,2022,22(5):4897-4902. DOI:10.16563/j.cnki.1671-6272.2022.10.005.
|
| [14] |
|
| [15] |
|
| [16] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 国际内分泌代谢杂志,2021,41(5):482-548. DOI:10.3760/cma.j.cn121383-20210825-08063.
|
| [17] |
中华医学会内分泌学分会. 中国高尿酸血症与痛风诊疗指南(2019)[J]. 中华内分泌代谢杂志,2020,36(1):1-13. DOI:10.3760/cma.j.issn.1000-6699.2020.01.001.
|
| [18] | |
| [19] |
中国疾病预防控制中心. 中国慢性病及其危险因素监测分析报告2004年[M]. 北京:中国协和医科大学出版社,2009.
|
| [20] |
|
| [21] | |
| [22] |
|
| [23] |
刘颖. 高尿酸对3T3-L1脂肪细胞IRS-1表达及其酪氨酸磷酸化水平的影响[D]. 长沙:中南大学,2013.
|
| [24] |
董洋,赵心迪,曹慧霞,等. 2型糖尿病患者血尿酸水平与肾功能损伤的相关性[J]. 中华实用诊断与治疗杂志,2022,36(5):456-459. DOI:10.13507/j.issn.1674-3474.2022.05.005.
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] | |
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
杨媛,周光清,李宛霖,等. 不同肥胖指标在高尿酸血症风险预测中的应用价值比较研究[J]. 中国全科医学,2022,25(4):453-460. DOI:10.12114/j.issn.1007-9572.2021.00.281.
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] | |
| [46] |
赵美茹,朱迪,刘淋,等. 简易胰岛素抵抗指标与698例2型糖尿病患者发生高尿酸血症风险的关联[J]. 山东大学学报(医学版),2022,60(12):44-51. DOI:10.6040/j.issn.1671-7554.0.2022.0575.
|
| [1] | HU Jian, LIU Min, JIAO Zengtao, JING Wenzhan, LIANG Wannian. Research on the Risk Level Assessment of Respiratory Infectious Disease Transmission: a Case Study of COVID-19-infected Public Places [J]. Chinese General Practice, 2026, 29(32): 4738-4744. |
| [2] | TANG Haoqing, LI Mingyue, LONG Ren, ZHU Yinbo, LIANG Weihuan, ZHU Ping, ZHAO Wei, ZHAO Yang, LIU Xiaoyun. Management Burden of Diabetic Mellitus Patients with Multimorbidity among Middle Aged and Older Adults: a Cross-sectional Survey in 6 Community Medical Institutes of China [J]. Chinese General Practice, 2026, 29(32): 4786-4797. |
| [3] | LI Bin, GE Mengfei, HAN Jing, XIAO Yu, ZHONG Yu. The Influencing Factors of Physical and Mental Health of the Elderly at Home in the Community and the Empowerment Strategies of Medical Social Workers [J]. Chinese General Practice, 2026, 29(31): 4627-4634. |
| [4] | WANG Zhongkai, WU Changyong, LI Menghan, LUO Yihua, ZHANG Bingqing, PENG Yunzhu. Association between Remnant Cholesterol Inflammatory Index and Risk of Cardiometabolic Multimorbidity in Middle-aged and Older Adults [J]. Chinese General Practice, 2026, 29(31): 4573-4581. |
| [5] | ZHANG Shuaishuai, CHEN Yue, QIU Jiaojiao, ZHU Ping, WANG Shuxia. Association between Remnant Cholesterol Inflammatory Index and Biological Age Acceleration in Middle-aged and Older Chinese Adults: a Nationwide Cohort Study [J]. Chinese General Practice, 2026, 29(30): 4397-4405. |
| [6] | HE Qizhen, ZHONG Qingling, XU Jin, YU Yi, ZHAO Yuefei. Perceptions and Experiences of Zero-time Exercise among Community-dwelling Older Adults: a Qualitative Study [J]. Chinese General Practice, 2026, 29(30): 4480-4488. |
| [7] | SUN Xiuqin, FENG Zhenlong, WEI Lanxuan, ZENG Yuxin, LIU Jinbo, MA Lin, AN Zhantian, WANG Hongyu. Analysis of the Current Status of Metabolic Syndrome among Middle-aged and Elderly People in Shijingshan District, Beijing, and Its Behavioral and Lifestyle Influencing Factors [J]. Chinese General Practice, 2026, 29(30): 4424-4430. |
| [8] | TANG Bo, YANG Rui, ZHAO Qian, LIU Hong, LIU Lidi, ZHANG Ying, JIANG Lihua, WANG Xiaogang, YANG Rong, LIAO Xiaoyang. Interpretation of the 2024 U.S. Preventive Services Task Force Recommendation Statement on Fall Prevention in Community-dwelling Older Adults [J]. Chinese General Practice, 2026, 29(30): 4360-4365. |
| [9] | CHEN Yujing, WANG Yan, LI Guang, DONG Benchao, YANG Peichuan, MA Jianxiong. Digital Technologies in the Management of Sarcopenia among Older Adults in Asia: a Scoping Review [J]. Chinese General Practice, 2026, 29(29): 4200-4210. |
| [10] | HUANG Jiating, LIU Lingna, NING Yanhua, SHI Jing, LI Xinjin, YANG Cailing, YAO Jing. Consistency between Expressed and Perceived Needs for Family Doctor Contracted Services among Rural Older Adults: a Survey of 456 Residents in Ningxia [J]. Chinese General Practice, 2026, 29(29): 4217-4225. |
| [11] | YU Xinyan, ZHANG Fang, GU Zhile, WANG Yanfang, SU Peng, ZHANG Haicheng. Correlation between Fasting Plasma Glucose, Body Mass Index, and Waist Circumference among Community-dwelling Elderly Individuals [J]. Chinese General Practice, 2026, 29(28): 4132-4140. |
| [12] | JIANG Huajie, ZHUO Lin, LI Xinyue, JIN Rui, MA Yue, CUI Jingqiu, WANG Xiuying. Related Factors and Preventive Measures of Hyperuricemia in Elderly Men [J]. Chinese General Practice, 2026, 29(27): 3915-3923. |
| [13] | JIAO Shuting, JING Haoran, ZHAO Yali. The Severity and Influencing Factors of Chronic Pruritus Symptoms in Elderly Patients Seeking Medical Treatment in Urban Communities in Beijing [J]. Chinese General Practice, 2026, 29(25): 3655-3663. |
| [14] | WANG Rui, LUO Shuoming, YANG Liang, WANG Peng, ZHAO Yang, WANG Qi, ZHOU Zhiguang. Diabetes Prevalence among Older Adults in China: a Systematic Review and Meta-analysis [J]. Chinese General Practice, 2026, 29(24): 3500-3508. |
| [15] | SUN Qinyu, DENG Yifan, YU Jiling, CAO Gan, YANG Tianxiao, FANG Zhen, JI Jun, HE Shenghu, ZHANG Jing. Study on the Predictive Value of Cumulative LDL-C Exposure and Uric Acid/HDL-C Ratio in Elderly Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2026, 29(24): 3447-3453. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||